"IC Research is a dedicated clinical research site in Murfreesboro, Tennessee (conveniently located 40 minutes south of Nashville) that conducts Phase II-IV clinical research studies in a variety of therapeutic areas for leading pharmaceutical companies."

During the past decade, International Clinical Research - Tennessee LLC conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 12 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 12 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "International Clinical Research - Tennessee LLC" #1 sponsor was "Incyte Corporation" with 7 trials, followed by "Dermira, Inc." with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Acrotech Biopharma Inc." with 2 trials sponsored and "Astellas Pharma Global Development, Inc." with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "International Clinical Research - Tennessee LLC" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Dermira, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "International Clinical Research - Tennessee LLC" are "Acne Vulgaris" (7 trials), "Atopic Dermatitis" (6 trials), "Dermatitis, Atopic" (2 trials), "Hot Flashes" (2 trials) and "Plaque Psoriasis" (2 trials). Many other conditions were trialed in "International Clinical Research - Tennessee LLC" in a lesser frequency.

Most popular intervention types in "International Clinical Research - Tennessee LLC" are "Drug" (25 trials), "Other" (4 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Ruxolitinib cream" (4 trials), "Vehicle" (4 trials), "Vehicle cream" (3 trials) and "Abrocitinib 200 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "International Clinical Research - Tennessee LLC" are 24 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "International Clinical Research - Tennessee LLC". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in International Clinical Research - Tennessee LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in International Clinical Research - Tennessee LLC, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".